The National Security Commission on Emerging Biotechnology (NSCEB) has produced an interim report that focuses on the potential of biotechnology to transform society and improve national security. The report discusses the United States’ longstanding leadership in biotechnology, the challenges posed by China’s rapid advancements in the field, and the need for the U.S. Government to develop a comprehensive strategy to address the risks and opportunities of emerging biotechnologies. The NSCEB examines areas such as regulatory oversight, workforce development, international cooperation, and responsible innovation, and provides concrete recommendations for government action. The report aims to ensure that the U.S. remains a global leader in biotechnology while safeguarding against potential misuse and promoting responsible use.
Read the NSCEB white paper here
After its first year of work, the U.S. National Security Commission on Emerging Biotechnology is pleased to publicly share its first report.
Throughout 2024, the Commission will work to advance the early ideas presented in this report, culminating in a comprehensive report to Congress in December 2024.
Biotechnology has the potential to bolster economic development in every community. If we capitalize on this unique opportunity, we can make this century the age of biology. A thriving biotechnology industry will enhance U.S. national security, strengthen and diversify the U.S. economy, and bolster a growing workforce. The Commission’s recommendations, when implemented, will ensure that the United States continues to lead the world in biotechnology development and deployment.
The podcast audio was AI-generated using Google’s NotebookLM
Share this post